Clinical Trial Update: Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with or without anlotinib for maintenance therapy in non-squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Non-squamous Non-small-cell Lung Cancer | Phase 2 | Status: UNKNOWN